THE ROLE OF TRANSANAL ENDOSCOPIC MICROSURGERY IN THE TREATMENT OF T1N0 RECTAL CANCER - CASE SERIES AND REVIEW OF THE LITERATURE. Mutafchiyski, V., Popivanov, G., Naseva, E., Vasil, K., Kjossev, K., Ivanov, P., Grigorov, G., Kotashev, G., Vasilev, K., & Penkov, M. International Journal of Surgery and Medicine, 2(2):50, 2016.
THE ROLE OF TRANSANAL ENDOSCOPIC MICROSURGERY IN THE TREATMENT OF T1N0 RECTAL CANCER - CASE SERIES AND REVIEW OF THE LITERATURE [link]Website  abstract   bibtex   
Currently, there has been an increasing trend toward transanal endoscopic microsurgery as a definitive treatment of T1 rectal cancer. Despite the promising results from the earlier series, the more recent studies reported a higher rate of local recurrences. Methods: A retrospective analysis of 20 patients with T1 rectal cancer managed by transanal endoscopic microsurgery is presented. Results: The patients were followed-up for mean 39.3 months. Local recurrences occurred in 5.3% of low-risk, 50% of high-risk T1 cases. The 3-year and 5-year cancer-specific survival in T1 group were 94.4% and 73.5%, respectively with mean time without LR was 81.5 months (90.5 months in the low-risk and 21 months in the high-risk group). Conclusion: The results corroborate the excellent prognosis for low-risk T1 cancers treated by TEM alone. For a high-risk T1 cancer adjuvant radiotherapy or conventional resection is highly recommended.
@article{
 title = {THE ROLE OF TRANSANAL ENDOSCOPIC MICROSURGERY IN THE TREATMENT OF T1N0 RECTAL CANCER - CASE SERIES AND REVIEW OF THE LITERATURE},
 type = {article},
 year = {2016},
 identifiers = {[object Object]},
 pages = {50},
 volume = {2},
 websites = {http://www.scopemed.org/fulltextpdf.php?mno=219235},
 id = {8ab3b29e-7c35-3048-8454-3fb8a9b959a5},
 created = {2017-03-27T21:00:42.237Z},
 accessed = {2017-03-27},
 file_attached = {false},
 profile_id = {5355b842-e534-326f-80e0-2f323ca218e2},
 group_id = {d0de29a3-0d31-36e3-a285-6c5371443de8},
 last_modified = {2017-03-27T21:00:42.237Z},
 tags = {adjuvant radiotherapy,early rectal cancer,risk factors,transanal endoscopic microsurgery},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {false},
 hidden = {false},
 private_publication = {false},
 abstract = {Currently, there has been an increasing trend toward transanal endoscopic microsurgery as a definitive treatment of T1 rectal cancer. Despite the promising results from the earlier series, the more recent studies reported a higher rate of local recurrences.
Methods:
A retrospective analysis of 20 patients with T1 rectal cancer managed by transanal endoscopic microsurgery is presented.
Results:
The patients were followed-up for mean 39.3 months. Local recurrences occurred in 5.3% of low-risk, 50% of high-risk T1 cases. The 3-year and 5-year cancer-specific survival in T1 group were 94.4% and 73.5%, respectively with mean time without LR was 81.5 months (90.5 months in the low-risk and 21 months in the high-risk group).
Conclusion:
The results corroborate the excellent prognosis for low-risk T1 cancers treated by TEM alone. For a high-risk T1 cancer adjuvant radiotherapy or conventional resection is highly recommended.},
 bibtype = {article},
 author = {Mutafchiyski, Ventsislav and Popivanov, Georgi and Naseva, Emilia and Vasil, Kyosev and Kjossev, Kirien and Ivanov, Plamen and Grigorov, Grigor and Kotashev, Georgi and Vasilev, Krasimir and Penkov, Marin},
 journal = {International Journal of Surgery and Medicine},
 number = {2}
}
Downloads: 0